Exploration Capital, LLC - Feb 20, 2024 Form 4 Insider Report for Fresh Tracks Therapeutics, Inc. (FRTX)

Role
10%+ Owner
Signature
Stephen L. Gustin on behalf of Exploration Capital, LLC
Stock symbol
FRTX
Transactions as of
Feb 20, 2024
Transactions value $
$68,665
Form type
4
Date filed
2/22/2024, 05:26 PM
Previous filing
Jan 17, 2024
Next filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FRTX Common Stock Purchase $44K +50K +5.88% $0.88 900K Feb 20, 2024 Direct F1, F2
transaction FRTX Common Stock Purchase $20.1K +22.3K +2.48% $0.90 922K Feb 21, 2024 Direct F1, F2
transaction FRTX Common Stock Purchase $4.66K +5.18K +0.56% $0.90 927K Feb 22, 2024 Direct F1, F2
holding FRTX Common Stock 47K Feb 20, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exploration Capital, LLC ("X-Cap") is the investment manager of Exploration Capital Fund, LP (the "Partnership") and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Exploration Capital General Partner, LLC (the "GP") is the general partner of the Partnership and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership.
F2 Stephen L. Gustin is the Managing Partner of X-Cap and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Mr. Gustin disclaims beneficial ownership of the reported securities held by the Partnership except to the extent of his pecuniary interest.
F3 These shares are directly owned by Stephen L. Gustin.